ACE2 and COVID-19: Moreover, the occurrence of cerebral hemorrhage in COVID-19 patients may be facilitated by SARS-CoV-2 interaction with its cellular receptor, the angiotensin-converting enzyme 2 (ACE2) (Wang et al., 2020).